Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Effects of Chlamydia trachomatis Infection on Fertility; A Case-Control Study

Authors
1 Vali-e- Asar Reproductive Health Research Center,Tehran Medical Sciences University, Tehran, Iran
2 Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Monoclonal Antibody Research Center, Avicenna Research Institute (ACECR), Tehran, Iran
4 Department of Biostatistics and Epidemiology, Fassa University of Medical Sciences, Fasa, Iran
5 Maternal-Fetal-Neonatal Health Research Center, Tehran University of Medical Sciences, Tehran, Iran
6 Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
7 Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran; International Campus, Tehran University of Medical Sciences, Kish Island, Iran
8 Consultant in sexual Medicine, Sheffield, United Kingdom
Abstract
Background: Nowadays, Chlamydia trachomatis is known as a causative agent of infertility. Because of, asymptomatic nature of infection, many may suffer from its lasting complications such as infertility. This study was performed in Tehran during April 2007 to April 2008 to compare the prevalence of Chlamydia trachomatis infection in fertile and infertile women using ELISA and PCR methods. Methods: Overall, 234 infertile and 223 pregnant women, as the fertile group, participated in this hospital-based case-control study. After completing an informed consent form and the questionnaire, first catch urine and blood sample were obtained for PCR and ELISA (IgG, IgM) tests, respectively. Logistic regression analysis was used to control possible confounding factors, and determine adjusted odds ratio of infertility due to the infection. Results: PCR results revealed that 29 (12.4%) of the infertile and 19 (8.5%) of the fertile women were positive for C. trachomatis infection (p=0.440). IgG was positive in 21 (9.0%) of the infertile and 11 (5.0%) in the fertile group (p=0.093). IgM assays identified that 2 (0.9%) of the infertile and 4 (1.8%) of the fertile women were positive for the micro-organism (p=0.375). Conclusion: We found no significant differences among fertile and infertile women for Chlamydia trachomatis infection. Nevertheless, molecular techniques which are more sensitive, more specific and non-invasive can be used to detect C. trachomatis infection.
Keywords

  1. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36(1):6-10.
  2. Centers for Disease Control and Prevention [Internet]. USA: Centers for Disease Control and Prevention; 2005 Sexually transmitted diseases surveillance; 2006 Nov [cited 2008 Oct 26]; Available from: http://www.cdc.gov/std/stats05/toc2005.htm
  3. Chen MY, Rohrsheim R, Donovan B. Chlamydia trachomatis infection in Sydney women. Aust N Z J Obstet Gynaecol. 2005;45(5):410-3.
  4. Chen MY, Donovan B. Changes in testing methods for genital Chlamydia trachomatis in New South Wales, Australia, 1999 to 2002. Sex Health. 2005;2(4):251-3.
  5. Stamm WE, Jones RB, Batteiger BE. Chlamydia trachomatis (trachoma, prinatal infections, lymphogranuloma venereum and other genital infections). In: Mandell GL, Dolin R, Bennette JE, editors. Principles and practice of infectious diseases. Philadelphia: Elsevier Churchill Livingstone; 2005. p. 2239-51.
  6. Guven MA, Dilek U, Pata O, Dilek S, Ciragil P. Prevalance of Chlamydia trochomatis, Ureaplasma urealyticum and Mycoplasma hominis infections in the unexplained infertile women. Arch Gynecol Obstet. 2007;276(3):219-23.
  7. Numazaki K, Asanuma H, Niida Y. Chlamydia trachomatis infection in early neonatal period. BMC Infect Dis. 2003;3:2.
  8. Wagenlehner FM, Weidner W, Naber KG. Chlamydial infections in urology. World J Urol. 2006;24(1):4-12.
  9. den Hartog JE, Morré SA, Land JA. Chlamydia trachomatis-associated tubal factor subfertility: Immunogenetic aspects and serological screening. Hum Reprod Update. 2006;12(6):719-30.
  10. Siemer J, Theile O, Larbi Y, Fasching PA, Danso KA, Kreienberg R, et al. Chlamydia trachomatis infection as a risk factor for infertility among women in Ghana, West Africa. Am J Trop Med Hyg. 2008;78(2):323-7.
  11. Al-Ramahi M, Mahafzah A, Saleh S, Fram K. Prevalence of Chlamydia trachomatis infection in infertile women at a university hospital in Jordan. East Mediterr Health J. 2008;14(5):1148-54.
  12. Malik A, Jain S, Hakim S, Shukla I, Rizvi M. Chlamydia trachomatis infection & female infertility. Indian J Med Res. 2006;123(6):770-5.
  13. Chamani-Tabriz L, Tehrani MJ, Akhondi MM, Mosavi-Jarrahi A, Zeraati H, Ghasemi J, et al. Chlamydia trachomatis prevalence in Iranian women attending obstetrics and gynaecology clinics. Pak J Biol Sci. 2007;10(24):4490-4.
  14. Jenab A, Roghanian R, Golbang N, Golbang P, Chamani-Tabriz L. Comparison of three meth-ods of DNA extraction in endocervical specimens for Chlamydia trachomatis infection by spectrophotometry, agarose gel, and PCR. Arch Immunol Ther Exp. 2010;58(3):227-34.
  15. Sharma M, Sethi S, Daftari S, Malhotra S. Evidence of chlamydial infection in infertile women with fallopian tube obstruction. Indian J Pathol Microbiol. 2003;46(4):680-3.
  16. Sambrook J, Russell DW. Molecular cloning: A laboratory manual. 3rd ed. New York: Cold Spring Harbor Laboratory Press; 2001. 2344 p.
  17. Sirmatel F, Sahin N, Sirmatel O, Telli E, Kececi S. Chlamydia trachomatis antigen positivity in women in risk groups and its relationship with the use of antibiotics. Jpn J Infect Dis. 2005;58(1):41-3.
  18. Kucinskiene V, Sutaite I, Valiukeviciene S, Milasauskiene Z, Domeika M. Prevalence and risk factors of genital Chlamydia trachomatis infection. Medicina. 2006;42(11):885-94.
  19. Corson SL. The role of laparoscopy in the infertility work-up. J Reprod Med. 1977;18(3):127-31.
  20. Centers for Disease Control and Prevention [Internet]. USA: Centers for Disease Control and Prevention; 2012. Sexually transmitted disease surveillance; 2002 [cited 2008 Oct 26]; Available from: http://www.cdc.gov/std/stats02/toc2002.htm
  21. Moaiedmohseni M, Owje M. The value of chlamydia trachomatis antibody testing in prediction of tubal factor infertility. J Family Reprod Health. 2008;2(1):29-32.
  22. Basirat Z, Sharbatdaran M, Montazar F. Comparison of anti Chlamydia antibodies in tubal and non-tubal infertile patients. J Mazandaran Univ Med Sci. 2006;16(55)118-24.
  23. Tukur J, Shittu SO, Abdul AM. A case control study of active genital Chlamydia trachomatis infection among patients with tubal infertility in northern Nigeria. Trop Doct. 2006;36(1):14-6.
  24. Taylor-Robinson D. Chlamydia trachomatis and sexually transmitted disease. BMJ. 1994;308 (6922):150-1.
  25. Olshen E, Shrier LA. Diagnostic tests for chlamydial and gonorrheal infections. Semin Pediatr Infect Dis. 2005;16(3):192-8.
  26. Newhall WJ, Johnson RE, DeLisle S, Fine D, Hadgu A, Matsuda B, et al. Head-to-head evaluation of five chlamydia tests relative to a quality-assured culture standard. J Clin Microbiol. 1999; 37(3):681-5.
  27. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev. 1997;10(1):160-84.
  28. Moncada J, Schachter J, Hook EW 3rd, Ferrero D, Gaydos C, Quinn TC, et al. The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and neisseria gonorrhoeae: the infected patient standard reduces sensitivity of single site evaluation. Sex Transm Dis. 2004;31(5):273-7.
  29. Shrier LA, Dean D, Klein E, Harter K, Rice PA. Limitations of screening tests for the detection of Chlamydia trachomatis in asymptomatic adolescent and young adult women. Am J Obstet Gynecol. 2004;190(3):654-62.
  30. van Doornum GJ, Schouls LM, Pijl A, Cairo I, Buimer M, Bruisten S. Comparison between the LCx Probe system and the COBAS AMPLICOR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in patients attending a clinic for treatment of sexually transmitted diseases in Amsterdam, The Netherlands. J Clin Microbiol. 2001;39(3):829-35.